ROCHESTER, MINN. -- Mayo Clinic researchers report "encouraging" results with a new treatment for women with metastatic breast cancer. The researchers tested a combination of two drugs -- paclitaxel and carboplatin -- on 53 women. They reported a response rate (that is, evidence of tumor shrinkage) in 62 percent of the women and a projected one-year survival rate of 72 percent -- after follow-up ranging from 12 to 21 months.
The above story is based on materials provided by Mayo Clinic. Note: Materials may be edited for content and length.
Cite This Page:
Mayo Clinic. "Encouraging Results Reported For New Breast Cancer Therapy." ScienceDaily. ScienceDaily, 9 February 2000. <www.sciencedaily.com/releases/2000/02/000209074955.htm>.
Mayo Clinic. (2000, February 9). Encouraging Results Reported For New Breast Cancer Therapy. ScienceDaily. Retrieved March 8, 2014 from www.sciencedaily.com/releases/2000/02/000209074955.htm
Mayo Clinic. "Encouraging Results Reported For New Breast Cancer Therapy." ScienceDaily. www.sciencedaily.com/releases/2000/02/000209074955.htm (accessed March 8, 2014).